Corrigendum to "The BACE1 product sAPPβ induces ER stress and inflammation and impairs insulin signaling" [Metab Clin Exp 85 (2018) 59-75]

Gaia Botteri, Laia Salvadó, Anna Gumà, D. Lee Hamilton, Paul J. Meakin, Gemma Montagut, Michael L. J. Ashford, Victoria Ceperuelo-Mallafré, Sonia Fernández-Veledo, Joan Vendrell, María Calderón-Dominguez, Dolors Serra, Laura Herrero, Javier Pizarro, Emma Barroso, Xavier Palomer, Manuel Vázquez-Carrera (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

Abstract

The authors have noticed that incorrect GADPH (Fig. 3F), IRS1 and GADPH (Fig. 3H) immnunoblots were inadvertently used when preparing the Figures. These errors have been corrected in the version of Fig. 3 included below. Please note that the mistake does not affect the results or conclusions of this work. [Figure presented] The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)101-102
Number of pages2
JournalMetabolism: Clinical and Experimental
Volume96
Early online date18 Apr 2019
DOIs
Publication statusPublished - Jul 2019

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint

Dive into the research topics of 'Corrigendum to "The BACE1 product sAPPβ induces ER stress and inflammation and impairs insulin signaling" [Metab Clin Exp 85 (2018) 59-75]'. Together they form a unique fingerprint.

Cite this